Was the Dalkon Shield  a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings

Mumford, Stephen; Kessel, E

doi:10.1016/s0015-0282(16)55068-7

Cited by 21 publications

(2 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…More importantly, no currently available IUD is associated with an increased risk of pelvic inflammatory disease. 22,23 This remains true even for people living with HIV, as demonstrated by a recent study from a cohort of 156 women living with HIV that did not demonstrate an association between HIV infection and IUD-related complications. 24 With regard to drug-drug interactions, it is thought that levonorgestrel IUDs exert their effects predominantly through local, not systemic, absorption; thus it is unlikely that ART inhibits their contraceptive efficacy.…”

Section: Copper and Levonorgestrel-releasing Intrauterine Devicesmentioning

confidence: 99%

“…Although concerns were raised in the 1970s about an association between a specific US‐marketed IUD and an increased risk of salpingitis, the data on which these concerns were based are not definitive. More importantly, no currently available IUD is associated with an increased risk of pelvic inflammatory disease 22,23 . This remains true even for people living with HIV, as demonstrated by a recent study from a cohort of 156 women living with HIV that did not demonstrate an association between HIV infection and IUD‐related complications 24 .…”

Section: Contraceptive Options For People Living With Hivmentioning

confidence: 99%

See 1 more Smart Citation

Contraception and Abortion Care for People Living With HIV: A Clinical Guide for Reproductive Health Practitioners

Yang,

Allen,

Cambou

et al. 2023

J Midwife Womens Health

View full text Add to dashboard Cite

People capable of pregnancy are disproportionately affected by HIV. Family planning needs and services are often unmet in this population, and clinical care guidelines regarding contraceptive options and abortion care are not well elucidated. Individuals living with HIV often face unique barriers in accessing contraception and abortion services due to internalized stigma, medically complex care (eg, drug–drug interactions, adverse effects of antiretroviral therapy), and distrust of health care providers. There is also a lack of clarity among reproductive health, primary, and infectious disease care providers on best‐practice contraceptive counseling and contraceptive care for individuals living with HIV, given limited opportunities to enhance expertise in reproductive infectious disease. In this review, we summarize existing and updated evidence and clinical considerations regarding contraceptive counseling and abortion care in this population.

show abstract

Section: Copper and Levonorgestrel-releasing Intrauterine Devicesmentioning

confidence: 99%

Section: Contraceptive Options For People Living With Hivmentioning

confidence: 99%